MTHFR, or the methylenetetrahydrofolate reductase is the key regulatory enzyme in folate and homocysteine metabolism
Novartis: Bimagrumab/BYM338 Bimagrumab is an antibody against activin type II receptor (ActRII) meaning that it acts as an ActRII antagonist (It prevents ActRII from functioning)
This means tirzepatide has anti-inflammatory pathways that semaglutide does not, operating through GIP receptor signaling
Because both berberine and semaglutide can cause gastrointestinal side effects and lower blood sugar , it may be wise to take them at different times
That distinction matters because weight loss should never be approached as a trend, shortcut, or one-size-fits-all protocol
Conuel EJ, Chieng HC, Fantauzzi J, Pokhrel K, Goldman C, Smith TC, Tiwari A, Chopra A, Judson MA